373 related articles for article (PubMed ID: 36979503)
1. MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity.
Kuang Z; Wu J; Tan Y; Zhu G; Li J; Wu M
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979503
[TBL] [Abstract][Full Text] [Related]
2. Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients.
Ruggeri C; Gioffré S; Achilli F; Colombo GI; D'Alessandra Y
Heart Fail Rev; 2018 Jan; 23(1):109-122. PubMed ID: 28944400
[TBL] [Abstract][Full Text] [Related]
3. Understanding the Protective Role of Exosomes in Doxorubicin-Induced Cardiotoxicity.
Zhang G; Yang X; Su X; An N; Yang F; Li X; Jiang Y; Xing Y
Oxid Med Cell Longev; 2022; 2022():2852251. PubMed ID: 36132225
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs as Biomarkers and Therapeutic Targets in Doxorubicin-Induced Cardiomyopathy: A Review.
Chen L; Xu Y
Front Cardiovasc Med; 2021; 8():740515. PubMed ID: 34901206
[TBL] [Abstract][Full Text] [Related]
5. Noncoding RNAs in doxorubicin-induced cardiotoxicity and their potential as biomarkers and therapeutic targets.
Fa HG; Chang WG; Zhang XJ; Xiao DD; Wang JX
Acta Pharmacol Sin; 2021 Apr; 42(4):499-507. PubMed ID: 32694762
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2.
Zhao L; Qi Y; Xu L; Tao X; Han X; Yin L; Peng J
Redox Biol; 2018 May; 15():284-296. PubMed ID: 29304479
[TBL] [Abstract][Full Text] [Related]
7. Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity.
Gioffré S; Ricci V; Vavassori C; Ruggeri C; Chiesa M; Alfieri I; Zorzan S; Buzzetti M; Milano G; Scopece A; Castiglioni L; Sironi L; Pompilio G; Colombo GI; D'Alessandra Y
Biomed Pharmacother; 2019 Feb; 110():1-8. PubMed ID: 30453253
[TBL] [Abstract][Full Text] [Related]
8. microRNA miR-133a as a Biomarker for Doxorubicin-Induced Cardiotoxicity in Women with Breast Cancer: A Signaling Pathway Investigation.
Alves MT; da Conceição IMCA; de Oliveira AN; Oliveira HHM; Soares CE; de Paula Sabino A; Silva LM; Simões R; Luizon MR; Gomes KB
Cardiovasc Toxicol; 2022 Jul; 22(7):655-662. PubMed ID: 35524907
[TBL] [Abstract][Full Text] [Related]
9. Circulating miRNA Profiles of Doxorubicin-induced Cardiotoxicity in Breast Cancer Patients.
Todorova VK; Makhoul I; Wei J; Klimberg VS
Ann Clin Lab Sci; 2017 Mar; 47(2):115-119. PubMed ID: 28442511
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in the diagnosis and prevention of drug-induced cardiotoxicity.
Skála M; Hanousková B; Skálová L; Matoušková P
Arch Toxicol; 2019 Jan; 93(1):1-9. PubMed ID: 30460422
[TBL] [Abstract][Full Text] [Related]
11. Nucleolin protects against doxorubicin-induced cardiotoxicity via upregulating microRNA-21.
Sun H; Tong Z; Fang Y; Jiang B; Liang P; Tang Y; Li Y; Wu Y; Xiao X
J Cell Physiol; 2018 Dec; 233(12):9516-9525. PubMed ID: 29968904
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs target the PI3K/Akt/p53 and the Sirt1/Nrf2 signaling pathways in doxorubicin-induced cardiotoxicity.
Yarmohammadi F; Ebrahimian Z; Karimi G
J Biochem Mol Toxicol; 2023 Feb; 37(2):e23261. PubMed ID: 36416353
[TBL] [Abstract][Full Text] [Related]
13. A Specific Circulating MicroRNA Cluster Is Associated to Late Differential Cardiac Response to Doxorubicin-Induced Cardiotoxicity
Ruggeri C; Gioffré S; Chiesa M; Buzzetti M; Milano G; Scopece A; Castiglioni L; Pontremoli M; Sironi L; Pompilio G; Colombo GI; D'Alessandra Y
Dis Markers; 2018; 2018():8395651. PubMed ID: 30627229
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress.
Zhao L; Tao X; Qi Y; Xu L; Yin L; Peng J
Redox Biol; 2018 Jun; 16():189-198. PubMed ID: 29524841
[TBL] [Abstract][Full Text] [Related]
15. The Tumor-Suppressive Human Circular RNA CircITCH Sponges miR-330-5p to Ameliorate Doxorubicin-Induced Cardiotoxicity Through Upregulating SIRT6, Survivin, and SERCA2a.
Han D; Wang Y; Wang Y; Dai X; Zhou T; Chen J; Tao B; Zhang J; Cao F
Circ Res; 2020 Jul; 127(4):e108-e125. PubMed ID: 32392088
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs as potential biomarkers for doxorubicin-induced cardiotoxicity.
Holmgren G; Synnergren J; Andersson CX; Lindahl A; Sartipy P
Toxicol In Vitro; 2016 Aug; 34():26-34. PubMed ID: 27033315
[TBL] [Abstract][Full Text] [Related]
17. Long-noncoding RNA MALAT1 sponges microRNA-92a-3p to inhibit doxorubicin-induced cardiac senescence by targeting ATG4a.
Xia W; Chen H; Xie C; Hou M
Aging (Albany NY); 2020 May; 12(9):8241-8260. PubMed ID: 32384281
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicular microRNAs as potential biomarker for early detection of doxorubicin-induced cardiotoxicity.
Beaumier A; Robinson SR; Robinson N; Lopez KE; Meola DM; Barber LG; Bulmer BJ; Calvalido J; Rush JE; Yeri A; Das S; Yang VK
J Vet Intern Med; 2020 May; 34(3):1260-1271. PubMed ID: 32255536
[TBL] [Abstract][Full Text] [Related]
19. Foxo3a inhibits mitochondrial fission and protects against doxorubicin-induced cardiotoxicity by suppressing MIEF2.
Zhou L; Li R; Liu C; Sun T; Htet Aung LH; Chen C; Gao J; Zhao Y; Wang K
Free Radic Biol Med; 2017 Mar; 104():360-370. PubMed ID: 28137654
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage response.
Kawano I; Adamcova M
Front Pharmacol; 2022; 13():1055911. PubMed ID: 36479202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
